Conversion Surgery for a Patient with cStage IV Gastric Cancer with Para-Aortic Lymphatic Metastases Who Achieved a Complete Pathological Response after First Line Nivolumab Plus Tegafur-Gimeracil-Oteracil/Oxaliplatin Therapy
Conversion Surgery for a Patient with cStage IV Gastric Cancer with Para-Aortic Lymphatic Metastases Who Achieved a Complete Pathological Response after First Line Nivolumab Plus Tegafur-Gimeracil-Oteracil/Oxaliplatin Therapy
Hiroaki Musha, Takefumi Suzuki, Takumi Kitaoka, Ryosuke Yamaga et al.
Journal
The Japanese Journal of Gastroenterological Surgery
Topics
Gastric Cancer Management and Outcomes
article
Conversion Surgery for a Patient with cStage IV Gastric Cancer with Para-Aortic Lymphatic Metastases Who Achieved a Complete Pathological Response after First Line Nivolumab Plus Tegafur-Gimeracil-Oteracil/Oxaliplatin Therapy